Replies to post #14617 on RespireRx Pharmaceuticals Inc (RSPI)

[dockside130]

Didn't Dr Stoll say they could not do a short term study on Altzheimers? Epix did and got quite a pop in share price. Why not do a similar study using an Ampakine?

On Tuesday, Epix Pharmaceuticals (nasdaq: EPIX - news - people ) announced that its Phase II clinical trial of experimental drug PRX-03140 showed "compelling" results. Alzheimer's patients who received 150-milligram doses of PRX-03140 orally once per day for two weeks achieved an average improvement of 5.7 points on the Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-cog). Those given 50-milligram doses once daily showed a 1.1 point improvement. Patients given a placebo averaged a .2 point decline

[fearfrost]

Just to clarify, this first trial in RD is going to be using CX717 orally (a pill) and not an injection yet, right?

[bigworld]

Aiming: I'd try an ampakine too. Perhaps it would make me a lot smarter and I would avoid investing in these types of companies that are slow roads to poverty.